Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation
Conditions:   Liver Transplant; Complications;   Hepatocarcinoma;   Recurrent Osteosarcoma;   High-Risk Cancer Intervention:   Drug: multi-kinase inhibitors in combination with bevacizumab Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials

PREPARE- Prehabilitation for Patients Awaiting Liver Transplantation: Feasibility and Acceptability Testing.
Condition:   Liver Transplant Intervention:   Behavioral: Prehabilitation Sponsors:   Belfast Health and Social Care Trust;   Queen's University, Belfast Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials